Paranasal Sinus Squamous Cell Carcinoma Unknown Status Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0050196 (Paranasal Sinus Squamous Cell Carcinoma)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01267240Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerTreatment